Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized. We found that BTLA levels were upregulated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Dong, Xubin, Song, Jingjing, Chen, Buran, Qi, Yufeng, Jiang, Wenjie, Li, Huihui, Zheng, Danni, Wang, Yinghao, Zhang, Xiaohua, Liu, Haiguang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7953043/
https://ncbi.nlm.nih.gov/pubmed/33718105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.592811
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars